Affordable Access

Lipsome-formulated enzymes for organophosphate scavenging: butyrylcholinesterase and Demeton-S.

Authors
  • Fischer, Sharon
  • Arad, Aya
  • Margalit, Rimona
Type
Published Article
Journal
Archives of biochemistry and biophysics
Publication Date
Feb 01, 2005
Volume
434
Issue
1
Pages
108–115
Identifiers
PMID: 15629114
Source
Medline
License
Unknown

Abstract

Butyrylcholinesterase-encapsulating bioadhesive liposomes are investigated as prophylactic scavengers of organophosphates for local administration to skin, eyes, airways, and lungs-gates through which organophosphates penetrate living systems. The systems were optimized with respect to: encapsulation efficiency; type of bioadhesive ligand bound to liposomes (collagen or hyaluronan); ligand density at the liposomal surface; retention of encapsulated-enzyme activity; protection of encapsulated enzyme from proteolysis; and scavenging the model organophosphate Demeton-S (DS). Monolayers of PC-12 cells were selected for feasibility testing based on: high affinity binding of the bioadhesive liposomes-DeltaG0 release upon binding ranged from -9 to -12 kcal/mol ligand; ability to mimic an organophosphate attack upon intact cells and measuring its impact on intracellular acetylcholinesterase. Under attack, unprotected cells lost 80-90% of intracellular enzyme activity. The loss was reduced to 20-30% for protected cells (pre-treated with the formulations), at the expense of liposomal Butyrylcholinesterase. These results support our prophylactic approach.

Report this publication

Statistics

Seen <100 times